New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop.
暂无分享,去创建一个
J. Downey | R. Gibbons | E. Braunwald | A. Arai | P. Ping | R. Kloner | R. Jennings | R. Gottlieb | R. Bolli | D. Yellon | C. Baines | D. Lefer | G. Heusch | R. V. Vander Heide | E. Murphy | M. Ovize | J. Vinten-johansen | R. Mentzer | M. Sack | K. Przyklenk | Lisa Schwartz Longacre
[1] R. Kloner,et al. Mild Hypothermia as a Cardioprotective Approach for Acute Myocardial Infarction: Laboratory to Clinical Application , 2011, Journal of cardiovascular pharmacology and therapeutics.
[2] D. Greiner,et al. Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes. , 2011, Antioxidants & redox signaling.
[3] V. Hasselblad,et al. Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. , 2011, JAMA.
[4] D. Mozaffarian,et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.
[5] J. Jensen,et al. ST-Segment resolution and clinical outcome with ischemic postconditioning and comparison to magnetic resonance. , 2010, American heart journal.
[6] R. Kim,et al. Molecular imaging: T2-weighted CMR of the area at risk—a risky business? , 2010, Nature Reviews Cardiology.
[7] M. Ugander,et al. A Pilot Study of Rapid Cooling by Cold Saline and Endovascular Cooling Before Reperfusion in Patients With ST-Elevation Myocardial Infarction , 2010, Circulation. Cardiovascular interventions.
[8] H. Bøtker,et al. Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations , 2010, Basic Research in Cardiology.
[9] R. Gottlieb,et al. Profound Cardioprotection With Chloramphenicol Succinate in the Swine Model of Myocardial Ischemia-Reperfusion Injury , 2010, Circulation.
[10] P. Kellman,et al. Magnetic Resonance Imaging Delineates the Ischemic Area at Risk and Myocardial Salvage in Patients With Acute Myocardial Infarction , 2010, Circulation. Cardiovascular imaging.
[11] P. Ferdinandy,et al. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. , 2010, Cardiovascular research.
[12] Michael V. Cohen,et al. Mechanism of Cardioprotection by Early Ischemic Preconditioning , 2010, Cardiovascular Drugs and Therapy.
[13] A. Kastrati,et al. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. , 2010, Journal of the American College of Cardiology.
[14] Z. Giricz,et al. Autophagy Induced by Ischemic Preconditioning is Essential for Cardioprotection , 2010, Journal of cardiovascular translational research.
[15] R. Gibbons,et al. Application of technetium-99m sestamibi single photon emission computed tomography in acute myocardial infarction: measuring the efficacy of therapy. , 2010, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[16] C. Terkelsen,et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial , 2010, The Lancet.
[17] R. Gottlieb,et al. Autophagy during cardiac stress: joys and frustrations of autophagy. , 2010, Annual review of physiology.
[18] G. Heusch,et al. Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection , 2010, Basic Research in Cardiology.
[19] W. J. Boscardin,et al. Effect of Supersaturated Oxygen Delivery on Infarct Size After Percutaneous Coronary Intervention in Acute Myocardial Infarction , 2009, Circulation. Cardiovascular interventions.
[20] M. Vogelzang,et al. Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial. , 2009, Circulation. Cardiovascular interventions.
[21] G. Heusch,et al. Loss of cardioprotection with ageing. , 2009, Cardiovascular research.
[22] R. Shannon,et al. Glucagon‐like Peptide‐1 and Myocardial Protection: More than Glycemic Control , 2009, Clinical cardiology.
[23] Einar Heiberg,et al. Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography. , 2009, JACC. Cardiovascular imaging.
[24] G. Heusch,et al. Cardioprotection: nitric oxide, protein kinases, and mitochondria. , 2008, Circulation.
[25] G. Heusch,et al. Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction. , 2008, European heart journal.
[26] W. Laskey,et al. Concordant improvements in coronary flow reserve and ST‐segment resolution during percutaneous coronary intervention for acute myocardial infarction: A benefit of postconditioning , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[27] Pierre Croisille,et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. , 2008, The New England journal of medicine.
[28] J. Schulz-Menger,et al. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. , 2008, Journal of the American College of Cardiology.
[29] C. Darling,et al. Aging mouse hearts are refractory to infarct size reduction with post-conditioning. , 2008, Journal of the American College of Cardiology.
[30] R. Kim,et al. Performance of Delayed-Enhancement Magnetic Resonance Imaging With Gadoversetamide Contrast for the Detection and Assessment of Myocardial Infarction: An International, Multicenter, Double-Blinded, Randomized Trial , 2008, Circulation.
[31] N. Weissman,et al. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE). , 2008, American heart journal.
[32] P. Ferdinandy,et al. Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning , 2007, Pharmacological Reviews.
[33] A. Hirayama,et al. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials , 2007, The Lancet.
[34] E. Murphy,et al. Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. , 2007, Cardiovascular research.
[35] I. Konstantinov,et al. Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning. , 2007, American journal of physiology. Heart and circulatory physiology.
[36] D. Duncker,et al. Cardiac effects of postconditioning depend critically on the duration of index ischemia. , 2007, American journal of physiology. Heart and circulatory physiology.
[37] J. Brachmann,et al. Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-Elevation Myocardial Infarction: the randomized multicentre CASTEMI study. , 2006, European heart journal.
[38] R. Gibbons,et al. Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial. , 2006, European heart journal.
[39] Xiaojing Ma,et al. Effect of postconditioning on coronary blood flow velocity and endothelial function and LV recovery after myocardial infarction. , 2006, Journal of interventional cardiology.
[40] R. Kloner,et al. The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion , 2006, Basic Research in Cardiology.
[41] Hiroshi Sato,et al. Cardioprotection by postconditioning in conscious rats is limited to coronary occlusions <45 min. , 2006, American journal of physiology. Heart and circulatory physiology.
[42] R. F. Hoyt,et al. Cardiac magnetic resonance imaging , 2004, Postgraduate Medical Journal.
[43] G. Finet,et al. Postconditioning the Human Heart , 2005, Circulation.
[44] R. Gibbons,et al. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). , 2005, Journal of the American College of Cardiology.
[45] M. Mocanu,et al. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. , 2005, American journal of physiology. Heart and circulatory physiology.
[46] L. Argaud,et al. Postconditioning Inhibits Mitochondrial Permeability Transition , 2005, Circulation.
[47] A. Jaffe,et al. The quantification of infarct size. , 2004, Journal of the American College of Cardiology.
[48] Stefan Neubauer,et al. Value of Delayed-Enhancement Cardiovascular Magnetic Resonance Imaging in Predicting Myocardial Viability After Surgical Revascularization , 2004, Circulation.
[49] R. Bolli,et al. Myocardial Protection at a Crossroads: The Need for Translation Into Clinical Therapy , 2004, Circulation research.
[50] R. Guyton,et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. , 2004, Cardiovascular research.
[51] Peipei Ping,et al. Role of the mitochondrial permeability transition in myocardial disease. , 2003, Circulation research.
[52] R. Guyton,et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. , 2003, American journal of physiology. Heart and circulatory physiology.
[53] R. Whitbourn,et al. Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. , 2002, Journal of the American College of Cardiology.
[54] D. Yellon,et al. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? , 2002, Cardiovascular research.
[55] O. Simonetti,et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.
[56] R. Kim,et al. Early Assessment of Myocardial Salvage by Contrast-Enhanced Magnetic Resonance Imaging , 2000, Circulation.
[57] O. Simonetti,et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.
[58] R. Califf,et al. Myocardial Infarction Adenosine as an Adjunct to Thrombolytic Therapy for Acute Myocardial Infarction , 1999 .
[59] F. Van de Werf,et al. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up. , 1997, Journal of the American College of Cardiology.
[60] B. Gersh,et al. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. , 1995, Circulation.
[61] J. Griffith,et al. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. , 1994, Circulation.
[62] R. Kloner,et al. Regional Ischemic 'Preconditioning' Protects Remote Virgin Myocardium From Subsequent Sustained Coronary Occlusion , 1993, Circulation.
[63] G. Lamas,et al. Ventricular remodeling after myocardial infarction. , 1993, Advances in experimental medicine and biology.
[64] M. Pfeffer,et al. Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.
[65] R. Jennings,et al. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.
[66] J. Lowe,et al. The Wavefront Phenomenon of Ischemic Cell Death: 1. Myocardial Infarct Size vs Duration of Coronary Occlusion in Dogs , 1977, Circulation.
[67] J. Covell,et al. Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions , 1971, Circulation.